Share-based Compensation (Tables)

3 Months Ended

Jun. 30, 2025

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Summary of share-based compensation expense

The following table summarizes the share-based compensation expense for grants included in the condensed consolidated statements of operations:

	Three Months Ended June 30,
(In thousands)	2025		2024
Product development	$	3,074	$	2,636
Sales and marketing		498		331
General and administrative		1,457		1,462
Total share-based compensation expense	$	5,029	$	4,429

Activity related SSARs award

The following table summarizes the activity during the three months ended June 30, 2025 for SSARs awarded under the 2020 and 2016 Plans:

(In thousands, except share and per share data)	Number of Rights			Weighted-Average Exercise Price		Remaining Contractual Term		Aggregate Intrinsic Value
				(per right)		(in years)
Outstanding at April 1, 2025		394,959		$	20.04
Granted		—			0.00
Exercised		(22,314	)		19.78
Forfeited		—			0.00
Expired		—			0.00
Outstanding at June 30, 2025		372,645		$	20.06		1.9	$	35,246
Exercisable at June 30, 2025		372,645		$	20.06		1.9	$	35,246
Vested at June 30, 2025		372,645		$	20.06		1.9	$	35,246

Activity related to restricted shares granted by the Company

The following table summarizes the activity during the three months ended June 30, 2025 for restricted shares granted under the 2020 Plan:

	Number of Shares			Weighted-Average Grant-Date Fair Value
				(per share)
Outstanding at April 1, 2025		229,710		$	76.01
Granted		4,970			100.19
Vested		(71,343	)		48.23
Forfeited		(1,393	)		79.10
Expected to vest at June 30, 2025		161,944		$	88.87

Employee Stock [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Schedule of principal assumptions utilized in valuing service condition SARs

We estimate the value of the call and put options using the Black-Scholes-Merton option pricing model with inputs including the closing market price of our common stock on the first date of the offering period and assumptions regarding the risk-free interest rate, expected term, and expected volatility of our common shares over the offering period based on historical volatility.

	Offering Period Ended			Offering Period Ended			Offering Period Ended
	June 30, 2025			December 31, 2024			June 30, 2024
Grant date fair value	$	131.71		$	103.43		$	81.60
Risk-free interest rate over contractual term		4.31	%		4.91	%		5.36	%
Expected term (in years)		0.49			0.50			0.41
Expected volatility		42.40	%		40.93	%		47.41	%

Restricted Stock Units (RSUs) [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Activity related to restricted shares granted by the Company

The following table summarizes the activity during three months ended June 30, 2025 for restricted stock units awarded under the 2020 and 2024 Plans:

	Number of Shares			Weighted-Average Grant-Date Fair Value
				(per share)
Outstanding at April 1, 2025		181,195		$	118.90
Granted		7,403			102.49
Vested		—			-
Forfeited		(1,661	)		129.95
Expected to vest at June 30, 2025		186,937		$	118.09